These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 1334723

  • 1. Effect of platelet agonists on the binding of platelet-activating factor to human platelets.
    Burgers JA, Akkerman JW.
    J Lipid Mediat; 1992 Sep; 5(3):289-300. PubMed ID: 1334723
    [Abstract] [Full Text] [Related]

  • 2. Desensitization of receptor-coupled activation of phosphoinositide-specific phospholipase C in platelets: evidence for distinct mechanisms for platelet-activating factor and thrombin.
    Morrison WJ, Shukla SD.
    Mol Pharmacol; 1988 Jan; 33(1):58-63. PubMed ID: 2827000
    [Abstract] [Full Text] [Related]

  • 3. Occupancy of platelet receptors for platelet-activating factor in asthmatic patients during an allergen-induced bronchoconstrictive reaction.
    Burgers JA, Bruynzeel PL, Mengelers HJ, Kreukniet J, Akkerman JW.
    J Lipid Mediat; 1993 Jun; 7(2):135-49. PubMed ID: 8400115
    [Abstract] [Full Text] [Related]

  • 4. 1,4-Dihydropyridines, a new class of platelet-activating factor receptor antagonists: in vitro pharmacologic studies.
    Ortega MP, García MC, Gijón MA, de Casa-Juana MF, Priego JG, Sanchez Crespo M, Sunkel C.
    J Pharmacol Exp Ther; 1990 Oct; 255(1):28-33. PubMed ID: 2170624
    [Abstract] [Full Text] [Related]

  • 5. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
    Tahraoui L, Floch A, Cavero I.
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1221-7. PubMed ID: 2156995
    [Abstract] [Full Text] [Related]

  • 6. Desensitization of platelet-activating factor-stimulated protein phosphorylation in platelets.
    Shukla SD, Morrison WJ, Dhar A.
    Mol Pharmacol; 1989 Apr; 35(4):409-13. PubMed ID: 2539556
    [Abstract] [Full Text] [Related]

  • 7. Platelet-activating factor stimulation of tyrosine kinase and its relationship to phospholipase C in rabbit platelets: studies with genistein and monoclonal antibody to phosphotyrosine.
    Dhar A, Paul AK, Shukla SD.
    Mol Pharmacol; 1990 Apr; 37(4):519-25. PubMed ID: 1691437
    [Abstract] [Full Text] [Related]

  • 8. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
    Tahraoui L, Floch A, Mondot S, Cavero I.
    Mol Pharmacol; 1988 Aug; 34(2):145-51. PubMed ID: 2842653
    [Abstract] [Full Text] [Related]

  • 9. Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors.
    Hwang SB, Lam MH, Hsu AH.
    Mol Pharmacol; 1989 Jan; 35(1):48-58. PubMed ID: 2536468
    [Abstract] [Full Text] [Related]

  • 10. Platelet-activating factor binding to human platelet membranes.
    Valone FH, Ruis NM.
    Biotechnol Appl Biochem; 1986 Oct; 8(5):465-70. PubMed ID: 3021183
    [Abstract] [Full Text] [Related]

  • 11. Natural 1-O-alkylglycerols reduce platelet-activating factor-induced release of [3H]-serotonin in rabbit platelets.
    Pédrono F, Cheminade C, Legrand AB.
    Prostaglandins Leukot Essent Fatty Acids; 2004 Jul; 71(1):19-23. PubMed ID: 15172680
    [Abstract] [Full Text] [Related]

  • 12. Occupancy of platelet receptors for platelet-activating factor in patients with septicemia.
    Lopez Diez F, Nieto ML, Fernandez-Gallardo S, Gijon MA, Sanchez Crespo M.
    J Clin Invest; 1989 May; 83(5):1733-40. PubMed ID: 2540221
    [Abstract] [Full Text] [Related]

  • 13. Antagonism of platelet activating factor receptor binding and stimulated phosphoinositide-specific phospholipase C in rabbit platelets.
    Morrison WJ, Shukla SD.
    J Pharmacol Exp Ther; 1989 Sep; 250(3):831-5. PubMed ID: 2550620
    [Abstract] [Full Text] [Related]

  • 14. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. I. Studies on blood platelets in vitro.
    Ostermann G, Hofmann B, Kertscher HP, Till U.
    J Lipid Mediat; 1990 Sep; 2(1):21-31. PubMed ID: 1966804
    [Abstract] [Full Text] [Related]

  • 15. The platelet-stimulating effect of adrenaline through alpha 2-adrenergic receptors requires simultaneous activation by a true stimulatory platelet agonist. Evidence that adrenaline per se does not induce human platelet activation in vitro.
    Steen VM, Holmsen H, Aarbakke G.
    Thromb Haemost; 1993 Sep 01; 70(3):506-13. PubMed ID: 8259557
    [Abstract] [Full Text] [Related]

  • 16. Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase.
    Tsironis LD, Mitsios JV, Milionis HJ, Elisaf M, Tselepis AD.
    Cardiovasc Res; 2004 Jul 01; 63(1):130-8. PubMed ID: 15194469
    [Abstract] [Full Text] [Related]

  • 17. Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.
    Imanishi N, Murakami-Uchida M, Koike H, Natsume Y, Morooka S.
    Arzneimittelforschung; 1994 Mar 01; 44(3):317-22. PubMed ID: 8192697
    [Abstract] [Full Text] [Related]

  • 18. [3H]52770 RP, a platelet-activating factor receptor antagonist, and tritiated platelet-activating factor label a common specific binding site in human polymorphonuclear leukocytes.
    Marquis O, Robaut C, Cavero I.
    J Pharmacol Exp Ther; 1988 Feb 01; 244(2):709-15. PubMed ID: 2831350
    [Abstract] [Full Text] [Related]

  • 19. Effect of SR 27417 on the binding of [3H]PAF to rabbit and human platelets and human polymorphonuclear leukocytes.
    Herbert JM, Laplace MC, Cailleau C, Maffrand JP.
    J Lipid Mediat; 1993 May 01; 7(1):57-78. PubMed ID: 8395255
    [Abstract] [Full Text] [Related]

  • 20. MK 287: a potent, specific, and orally active receptor antagonist of platelet-activating factor.
    Hwang SB, Lam MH, Szalkowski DM, MacIntyre DE, Bach TJ, Luell S, Meuer R, Sahoo SP, Alberts AW, Chabala JC.
    J Lipid Mediat; 1993 Jun 01; 7(2):115-34. PubMed ID: 8400114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.